Attenuated innate immune defenses in very premature neonates during the neonatal period

Abstract

Background

Anti-microbial responses have been shown to be profoundly attenuated in very preterm neonates when examined on cord blood. However, we lack data on these responses at the time these neonates are most vulnerable to infections.

Methods

Multiple cytokine responses to two prototypic Toll-like receptor (TLR) agonists: LPS (TLR4) and R848 (TLR7/8) were prospectively measured in preterm neonates born ≤30 weeks of gestation (n=50) during the first 28 days of age using whole blood and single-cell multi-parameter flow cytometry assays. Results were compared to term neonates (n=30) and adult controls (n=25).

Results

In preterm neonates, LPS and R848 responses remained attenuated in both cord blood and in the first 28 days of age. These responses showed significant maturation over time after adjusting for gestational age and were confirmed in blood monocytes and dendritic cells on a per-cell basis. We detected no major contribution of chorioamnionitis, maternal antenatal corticosteroids or magnesium sulfate treatment, labor, or mode of delivery to the maturation of cytokine responses.

Conclusion

Innate immune anti-microbial defenses are profoundly attenuated developmentally in very preterm neonates during the neonatal period, suggesting that exogenous factors drive the sustained systemic inflammation that has been linked to increased morbidities in these infants.

INTRODUCTION

Despite improvements in neonatal health care, mortality from infections has continued to increase in very preterm neonates over the last two decades, owing to the improved survival of smaller and more vulnerable infants (1). However, the underlying immunological basis of their high morbidities and high vulnerability to sepsis remains poorly understood (2). To defend themselves against infection, neonates rely on first-line, innate immune defense mechanisms. These mechanisms include the detection of specific microbial molecular structures called Pathogen-Associated Molecular Patterns (PAMP) through specialized receptors termed Pattern Recognition Receptors (PRR), but also other defense mechanisms such as phagocytosis and antigen presentation to the adaptive immune system.

It is widely stated that the high risk of neonatal sepsis observed in these infants is due to immature immune defense mechanisms. However, data are lacking on the development of immune functions beyond measures performed on umbilical cord blood. Recent studies have reported reduced antigen-presenting receptor expression during the first week of age in infants born below 33 weeks of gestation (3, 4). In contrast, phagocytic functions in these infants are more comparable to term infants (5). Toll-like receptors (TLRs) play a predominant role as a major family of PRR that act as essential “detectors” in the recognition of microbial pathogens by the innate immune system. We and others have shown that TLR-induced cytokine immune reactivity are profoundly attenuated in cord blood of very preterm neonates and develops asynchronously over the last trimester of gestation (6–10). These infants also display sustainably high levels of systemic inflammation, indicating a potential immune dysregulation that has also been associated with worsened clinical outcomes (11). On the other hand, cord blood responses may not adequately reflect important developmental adaptation occurring during the first few weeks after birth. Also, it is unclear to what extent specific perinatal events may induce an earlier maturation of PRR responsiveness during the neonatal period in these infants, resulting in an hyper-reactive state (12).

In this study, we determined anti-microbial TLR-induced cytokine responses in very preterm neonates over the first 28 days of age. We showed that these responses remain markedly attenuated during the neonatal period both as confirmed using whole blood measures and on a per-cell basis in main circulating innate immune cells. These data provide indispensable support to the premise that reduced innate immunity may contribute to the increased risk of neonatal sepsis in this age group.

RESULTS

Attenuated post-natal immune responses in very preterm neonates

Clinical characteristics of preterm subjects are provided in Table 1. To determine the extent to which very preterm neonates were able to respond to PAMP during the neonatal period, whole blood cytokine responses to two prototypic TLR agonists were compared between very preterm neonates (n = 50) on both cord and post-natal blood, term infants (n = 30) and adult controls (n = 25). Expectedly, cord blood LPS and R848 responses were markedly reduced in very preterm neonates (Figure 1). When comparing TLR responses in very preterm infants as a function of post-natal age, significant increase was also observed over the first 28 days of age (Figure 1). The distribution of gestational age in very preterm infants was identical between time periods, excluding significant effects due to the degree of gestational maturation at birth (Supplemental Figure S1, online). However, to more fully account for an effect due to gestational age, post-natal TLR reactivity was analyzed in very preterm neonates according to post-natal days used as a continuous variable, in regression models. Estimates of effects are presented in Table 2 and quantify the increase in TLR responsiveness for each increase in post-natal days independent of gestational age, within the group of very preterm neonates. These results confirmed a large effect of post-natal age on most LPS and R848 cytokine responses. Indeed, significant residual influences of post-natal age were detected for IL-6 responses (using R848), TNF-α (for both LPS and R848) and IL-12/23p40 (for both LPS and R848) (p<0.05).

Table 1.

Clinical characteristics of very preterm neonates

Clinical Characteristics	N = 50
Gestational Age (weeks; mean +/− SD)	27.2 +/− 2.1
Birth weight (g; mean +/− SD)	1051 +/− 370
Gender (% male) (95% CI)	67 (54, 81)
Received antenatal corticosteroids (%) (95% CI)	87 (72, 101)
Presence of labor (%) (95% CI)	70 (56, 83)
Received antenatal MgSO4 (%) (95% CI)	76 (62,90)
Born by caesarian section (%) (95% CI)	70 (56, 83)
Histological chorioamnionitis (%) (95% CI)	49 (34, 63)
SNAP score at birth (median, IQR)	26, 14 – 49

SD: standard deviation; CI: confidence interval; MgSO₄: magnesium sulfate; SNAP scores were recorded within 12 hours of birth; IQR: inter-quartile range.

Figure 1. Toll-like receptor cytokine responses.

Whole blood (A) pro- and (B) anti-inflammatory cytokine responses in very preterm neonates grouped by sampling period on cord blood, 2–14 days and 15–28 days of age, and in term neonates and adults, following stimulation with LPS or R848 (bars represent median). Unstimulated cytokine levels (median) were undetectable (≤0 pg/ml) in all cases (not shown). Significant differences in cytokine responses across all three groups of very preterm neonates and term neonates, as determined using an ANOVA, are shown as a capped-end line (*p<0.05; **p<0.01; †p<0.001). Statistical comparisons within each subgroup, as determined using a Dunn’s post-test taking into account multiple comparisons, is shown as straight lines (p<0.05).

Table 2.

Changes in Toll-like receptor responses by post-natal age, adjusted for gestational age

Toll-like receptor ligand	Cytokine	Estimates of effects (95%CI)	P value
Lipopolysaccharide (LPS)	IL-1β	742 (−140, 1631)	0.107
	IL-6	21301 (−1036, 43637)	0.068
	TNF-α	2450 (560, 4340)	0.014*
	IL-12/23p40	6076 (770, 11382)	0.029*
	IL-10	364 (−21, 756)	0.069
R848	IL-1β	2779 (−210, 5775)	0.075
	IL-6	36253 (10675, 61838)	0.008**
	TNF-α	76321 (490, 12663)	0.005**
	IL-12/23p40	17703 (6790, 28616)	0.003**
	IL-10	1939 (−308, 4186)	0.098

^*p<0.05;

^**p<0.01

Toll-like receptor reactivity at the single-cell level in very preterm neonates

To ascertain that the attenuated TLR reactivity was not due to a lack of circulating immune cells in whole blood, cell compositions were enumerated using flow cytometry. Monocyte proportions were substantially higher in very preterm neonates during the neonatal period, compared to term neonates, adults, or even compared to preterm cord blood samples, whereas proportions of granulocytes, lymphocytes and dendritic cells were comparable (Supplemental Figure S2, online).

To further exclude a lack of cytokine-producing cells, TLR-induced production of IL-6, TNF-α and p40,, a shared molecular subunit between the cytokine IL-12 and IL-23, were also analyzed at the single cell level by intracellular cytokine flow cytometry detection in two main cytokine-producing innate immune blood cell types: CD14-expressing monocytes and CD11c-expressing dendritic cells. A representative flow cytometry diagram of intracellular cytokine responses from a representative very preterm infant is shown in Supplemental Figure S3, online). As shown in Figure 2, production of IL-6 and TNF-α was substantially reduced in a subgroup of very preterm infants both in monocytes, compared to term neonates or adults. Dendritic cells are by and large the main source of IL-12/23p40 in human blood. IL-12 and IL-23 are two cytokines important in the differentiation of T helper lymphocyte immune responses (7). Similar to the reduced IL-6 and TNF-α responses observed in preterm monocytes, production of IL-12/23p40 was also markedly reduced in dendritic cells from both term and preterm neonates (Figure 2). Collectively, these data confirm that innate immune cells are present in preterm neonates but further indicate that these cells are hypo-reactive to TLR stimulation in vitro.

Figure 2. Single-cell cytokine production in innate immune cells.

Single-cell (A) LPS- and (B) R848-induced cytokine responses (black circles) in monocytes (for IL-6 and TNF-α) and in dendritic cells (for IL-12/23p40) in very preterm neonates (mean gestational age and birth weight: 27.2 weeks and 1063 g, respectively; median post-natal age: 13 days, range 7 to 23), term neonates and adults, compared to unstimulated responses (gray squares); *p<0.05; **p<0.01.

Contribution of perinatal factors to the maturation of post-natal innate immune responses

To assess whether responses were independently influenced by common perinatal factors linked to prematurity (including chorioamnionitis; antenatal corticosteroids; presence of labor; mode of delivery of the infant; and use of magnesium sulfate), the contribution of these factors was examined in the group of very preterm neonates using partial correlations, adjusting for gestational age. As shown in Figure 3, none of the factors had significant effects on the ontogeny of innate cytokine production, indicating a developmental maturation rather than attenuation due to exogenous perinatal factors.

Figure 3. Effect of perinatal factors on the post-natal maturation of Toll-like receptor responses.

Data show correlations (y-axis) adjusted for gestational age, with 95% confidence intervals (bars). Lipopolysaccharide (black symbols) and R848 (white symbols) responses by cytokine; IL-1β (circle), IL-6 (square), TNF-α (upward triangle), IL-12/23p40 (diamond), IL-10 (downward triangle); CA: chorioamnionitis; ANS: antenatal corticosteroids.

DISCUSSION

To our knowledge, this is the first study that measured anti-microbial reactivity in very preterm neonates during the neonatal period. We confirm profoundly attenuated post-natal responses, consistent with responses measured on cord blood (7, 8). The use of single-cell flow cytometry allows confirmation that the functional attenuation in TLR responsiveness is not due to a lack of innate immune cell composition. The measure of responses on whole blood provides a more global determination of anti-microbial responses. Indeed, previous studies have demonstrated that neonatal plasma suppresses TLR-mediated cytokine production, indicating that both cellular and soluble humeral factors are important in the functional determination of immune responsiveness (13, 14).

Our data are consistent with previous studies that have measured a low surface expression of TLRs on blood mononuclear cells of preterm neonates, with TLR2 and TLR4 expression increasing during the first 2 months of age (15). However, because TLR-dependent cytokine responses generally correlate poorly with their corresponding receptor gene or protein expression, it is important to validate the impact of a reduced expression of PRR at the functional level by examining relevant cytokine responses (6). Others reported that endotoxin (TLR4) responses in monocytes from preterm neonates born below 32 weeks of gestation are already mature (i.e. comparable to responses measured at the full term of gestation) by the second week of age, although it remained unclear whether this is also true of infants born at the lower end of gestation (15).

Our data help address an important paradox in neonatal research. High circulating levels of inflammatory cytokines have been observed in very preterm infants exposed to intensive care (11) and have been repeatedly linked to worse outcomes such as bronchopulmonary dysplasia (12), white matter injury, and neurodevelopmental impairments (16). These results have led to speculations that the innate immune system of these infants is hyper- rather than hypo-responsive during the neonatal period (17). However, this hypothesis was based mainly on random measures of inflammatory mediators in serum, and had, to the best of our knowledge, never been confirmed by functional data measuring the ‘reactivity’ of the post-natal innate immune system. In fact, studies using cord blood have consistently shown that the innate immune defenses of the very preterm infants are hypo-reactive to PRR stimulation, compared to term-born infants or adults. Our data extend these observations, namely that very preterm neonates continue to display decreased TLR-agonist induced production of both pro-inflammatory (IL-1β, IL-6, TNF-α, IL-12/23p40) and regulatory (IL-10) cytokines over the entire first month of life. Also, previous cord blood studies have suggested that immune cells from very preterm neonates may in fact be biased toward an anti-inflammatory state characterized by higher IL-10 production compared to other pro-inflammatory cytokine responses (7). However, this was not observed in our current study. This then raises the question: why are basal levels of inflammation elevated in the very preterm neonates during the neonatal period? A possible explanation is that the high basal inflammation reflects an ongoing, continuous exposure to stimulation in the context of repeated oxidative stress due to mechanical ventilation, supplemental oxygen or sepsis. Additionally, the high circulating levels of systemic inflammation in these infants may reflect impaired mechanisms of active resolution of the inflammation rather than a sustained activation. The possibility that worse outcomes may result from a premature immune maturation of anti-microbial responses does raise potential clinical concerns of using experimental therapies aiming to “boost” immune reactivity at an earlier stage, in order to prevent neonatal infections in this age group.

TLRs play a critical role in protecting against microbes in early life, as indicated by an increased vulnerability to specific bacterial and viral infections in humans with loss-of-function mutations along these molecular pathways (18). The risk of infections in these patients is greatest during the neonatal/early childhood period, underlining the importance of these receptors for immune protection during infancy (18, 19). As shown from previous epidemiological studies, the incidence of sepsis sharply increases in these infants shortly after birth, peaking during the first week of post-natal age, then slowly declining thereafter (20, 21). Although additional reasons may underlie the increased vulnerability of these infants to sepsis, including a high need for invasive life-saving interventions early on, and the prompt microbial colonization of their skin and mucosal membranes after birth, our data mirror this period of vulnerability. This window of vulnerability temporally delineates a high risk period during which exposure to skin- or mucosal-breaking invasive interventions should be insistently minimized, in order to limit the risk of sepsis. Overall, these data provide essential support to the premise that the increased risk of infection in very preterm neonates is due to a developmental immaturity of innate immune anti-microbial responses.

Some limitations to our study should be acknowledged. Due to a limited number of preterm infants enrolled, we were unable to determine the relationship between attenuated anti-microbial responses and an increased risk of sepsis, or other clinical outcomes. Also, we were unable to detect an effect of perinatal factors, (i.e. chorioamnionitis, antenatal corticosteroids, exposure to magnesium sulfate, presence of labor, etc.) on the maturation of innate immune responses in the group of very preterm infants. Although our analysis was not specifically powered to detect subtle effects, again due to a limited sample size, we can exclude large effects related to an exposure to antenatal corticosteroids or chorioamnionitis that could be implied from animal models (22, 23). Our study also highlights the importance of corroborating observation in populations of human infants, even if ethically challenging, in order to validate animal observations. Moreover, our study certainly informs as to the considerably larger sample size that would be required in order to detect more subtle effects from perinatal factors on the maturation of innate immune functions.

In conclusion, we show that the ability of very preterm neonates to respond to PAMP is profoundly attenuated over the first month after birth in very preterm neonates, yet with considerable heterogeneity in the degree and timing of post-natal maturation. Our data are directly relevant to our understanding of how and when immaturity of the developing innate immune system contributes to an increased risk of sepsis in these infants. Future studies are required to understand how variability in immune responses among individuals affects clinical outcomes.

METHODS

Study population

Neonates were prospectively enrolled at the British Columbia Children’s & Women’s Health Centre (Vancouver, Canada) between June 2012 and March 2014, after parental informed consent. Preterm neonates born below 30 weeks of gestation admitted to the Neonatal Intensive Care Unit were sampled once, according to a gestational age-matched schedule where blood was taken during either periods of 2 to 14, or 15 to 28 days of age in order to distribute subjects evenly across post-natal days. All peripheral blood samples were coordinated with other early morning routine blood taking. Also, samples were scheduled to be collected at least 48 hours away from a blood product transfusion, or from post-natal corticosteroid administration. Infants who were actively diagnosed with suspected or proven sepsis or under antibiotic treatment were excluded. For external validation, the amount of exposure to supplemental oxygen, mechanical ventilation, parenteral nutrition, and use of intravenous sedation (either morphine or midazolam) at time of blood sampling in preterm neonates is also provided in Supplemental Table S1, online). To further confirm generalizability of our findings, white blood cell composition was determined using a diagnostic automated cell count for neutrophils, monocytes and lymphocytes in the subgroup of very preterm neonates throughout the study period, as part of routine clinical care and were within expected normal ranges (see Supplemental Figure S4, online). Cord blood samples were also obtained from healthy control neonates delivered at term by elective Caesarean section and from peripheral blood of healthy adults using identical protocols and reagent batches. All blood samples were collected in sodium heparin BD Vacutainer tubes (Becton Dickinson, Mississauga, Canada) and processed within one hour of collection. To avoid an experimental historical bias during recruitment, a proportional number of preterm, term, and adult subjects were tested over the course of the study. Chorioamnionitis was defined histologically as previously described (11). Antenatal corticosteroid and magnesium sulfate exposure were defined as occurring within 72 and 24 hours prior to delivery, respectively. SNAP scores were determined as described (24). The study was approved by the University of British Columbia Children’s & Women’s Research Ethics Board (#H07-02681).

Immune stimulation and cytokine measures

To limit experimental variability in our assays, TLR agonists were pre-diluted in batches at the beginning of the study in quantities sufficient for 6-month periods in accordance with pre-study stability tests done of all main reagents used in the study (data not shown). To ensure stability of the reagents, each ligand batch was also tested against a group of adult subjects at regular intervals (not shown). Whole blood was diluted 1:2 with RPMI 1640 medium with L-glutamine (Gibco, Grand Island, NY) and stimulated with saturating doses of the TLR4 agonist lipopolysaccharide (LPS, 100 ng/ml; InvivoGen, San Diego, CA), the TLR7/8 agonist R848 (1 μg/ml; InvivoGen), or unstimulated, for 24 hours at 37°C in 5% CO₂ atmosphere in pre-diluted aliquots round-bottom 96-well microplates. The concentration of TLR agonists used in this study corresponded to peak stimulating concentrations, as determined in our previous studies (7, 25). Following stimulation, cell supernatants were stored at −80°C for batches analyses. Cytokine measurements were performed in duplicates using commercially available enzyme-linked immunosorbent assays (ELISA) for the following cytokines: IL-1β, IL-6, IL-10 and TNF-α (eBioscience, San Diego, CA) and IL-12p40 (BioLegend, San Diego, CA), as described (7). Mean intra-assay coefficients of variability for all cytokine-stimulated levels consistently were below 15%. In each age group, half of the subjects were also randomly sampled in parallel for use in whole blood immune cell composition and intracellular cytokine production assays, using flow cytometry as described (7). For flow cytometry analyses, the following antibodies were used: Alexa Fluor 700-conjugated anti-CD11c, PE-Cy7-conjugated anti-CD14, eVolve605-conjugated anti-CD19 and PerCP-Cy5.5-conjugated anti-HLA-DR (eBioscience), and PE-conjugated anti-CD3 (BD Biosciences, Mississauga, Canada) for identification of monocytes (HLA-DR, CD14), myeloid dendritic cells (HLA-DR, CD11c), B cells (CD19), T cells (CD3) and polymorphonuclear cells (by forward and side scatter), as described (7). For intracellular cytokine detection, cells were incubated in presence of brefeldin A (10 μg/μl, Sigma Aldrich, St. Louis, MO) and the following additional antibodies were used (after permeabilization): Pacific Blue-conjugated anti-CD3 (instead of PE-conjugated, BioLegend), APC-conjugated or FITC-conjugated anti-IL-6, PE-eFluor610-conjugated TNF-α and PE-conjugated-IL-12/23p40 (eBioscience), as described (7). No significant cytokine production was detected in unstimulated polymorphonuclear cells (not shown). In all flow cytometry analyses, cells were also stained using FITC-conjugated anti-glycophorin A to allow gating out of any residual red blood cells in the sample and gates were adjusted using fluorescence-minus one controls (for cell surface markers) and unstimulated control samples (for cytokine detection). Data was analyzed using the FlowJo software (FlowJo vX 10.0.7r2; FlowJo LLC, Ashland, Oregon).

Statistical Analyses

Differences between stimulated and baseline cytokine responses were compared between age groups using non-parametric testing (Mann-Whitney U) and were all highly significant (p<0.0001; data not shown). In initial analyses, responses within the whole group of preterm neonates were assessed using linear regressions and were shown to be independent of whether samples were collected at the time of birth from cord blood (labeled as day 1), or from postnatal peripheral blood. This finding was then confirmed using analysis of covariance incorporating post-natal age as a continuous variable, where cytokine responses were then compared between cord and peripheral blood (data not shown); therefore all cord and peripheral blood samples were combined in subsequent analyses. To determine the impact of post-natal age, differences between groups were compared using a one-way ANOVA, as a function of post-natal age (categorized as preterm cord blood, preterm day 2–14 and preterm day 15–28, term) and using a post-test Dunn’s correction for multiple testing (p<0.05). In subsequent analyses, the relative contributions of gestational age and the independent effect of post-natal age were confirmed within the subgroup of very preterm neonates, using multiple linear regressions where both parameters (gestational and post-natal age) were included as continuous variables. The residual contributions of perinatal factors (chorioamnionitis: yes/no, antenatal corticosteroids: yes/no, presence of labor: yes/no, mode of delivery of the infant: vaginal/C-section and use of magnesium sulfate: yes/no) were individually assessed using partial correlations, with adjustment for gestational age (as a continuous variable). Associated 95% confidence intervals were obtained using the bootstrap.